NEJM Interview: Prof. Timothy Jost on litigation challenging the consideration of race and ethnicity in the allocation of scarce Covid-19 treatments.
NEJM Interviews
00:00
Introduction
Black, indigenous and latinex people have been at high risk for poor outcomes during the pandemic. Including race or ethnicity as factor in allocation policies raises serious legal issues. A lot of them have to do with economic status and poor living conditions on average.
Transcript
Play full episode
